Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric Population.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
19 Oct 2022
Historique:
pubmed: 8 9 2022
medline: 22 10 2022
entrez: 7 9 2022
Statut: ppublish

Résumé

Children are prone to bloodstream infections (BSIs), the rapid and accurate diagnosis of which is an unmet clinical need. The T2MR technology is a direct molecular assay for identification of BSI pathogens, which can help to overcome the limits of blood culture (BC) such as diagnostic accuracy, blood volumes required, and turnaround time. We analyzed results obtained with the T2Bacteria (648) and T2Candida (106) panels in pediatric patients of the Bambino Gesù Children's Hospital between May 2018 and September 2020 in order to evaluate the performance of the T2Dx instrument with respect to BC. T2Bacteria and T2Candida panels showed 84.2% and 100% sensitivity with 85.9% and 94.1% specificity, respectively. The sensitivity and specificity of the T2Bacteria panel increased to 94.9% and 98.7%, respectively, when BC was negative but other laboratory data supported the molecular result. T2Bacteria sensitivity was 100% with blood volumes <2 mL in neonates and infants. T2Bacteria and T2Candida provided definitive microorganism identification in a mean time of 4.4 and 3.7 h, respectively, versus 65.7 and 125.5 h for BCs (

Identifiants

pubmed: 36069557
doi: 10.1128/jcm.00292-22
pmc: PMC9580347
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0029222

Références

Clin Microbiol Infect. 2013 Jun;19(6):513-20
pubmed: 23490046
Clin Infect Dis. 2015 Mar 15;60(6):892-9
pubmed: 25586686
J Emerg Med. 2020 May;58(5):785-796
pubmed: 31982197
Curr Opin Infect Dis. 2019 Oct;32(5):497-504
pubmed: 31335441
Clin Microbiol Infect. 2015 Apr;21(4):302-12
pubmed: 25743999
Clin Microbiol Infect. 2020 Feb;26(2):168-173
pubmed: 31654793
Clin Microbiol Infect. 2019 Mar;25(3):326-331
pubmed: 29879482
Clin Chest Med. 2016 Jun;37(2):191-207
pubmed: 27229637
Open Forum Infect Dis. 2020 Feb 27;7(3):ofaa075
pubmed: 32195291
Lancet Infect Dis. 2017 Apr;17(4):381-389
pubmed: 28089444
Open Forum Infect Dis. 2019 Mar 25;6(5):ofz136
pubmed: 31069244
Pediatr Crit Care Med. 2005 Jan;6(1):2-8
pubmed: 15636651
Ann Intern Med. 2019 Jun 18;170(12):845-852
pubmed: 31083728
J Clin Microbiol. 2016 Jun;54(6):1418-1424
pubmed: 26818669
Rev Iberoam Micol. 2018 Jul - Sep;35(3):159-161
pubmed: 30343837
Pediatr Res. 2017 Oct;82(4):574-583
pubmed: 28574980
Eur J Clin Microbiol Infect Dis. 2011 Sep;30(9):1127-34
pubmed: 21373774
Am J Infect Control. 2015 Nov;43(11):1222-37
pubmed: 26298636
Arch Dis Child Educ Pract Ed. 2014 Aug;99(4):144-51
pubmed: 24334340
BMC Pediatr. 2021 Apr 21;21(1):188
pubmed: 33882891
Future Microbiol. 2016;11(1):103-17
pubmed: 26371384
Stat Med. 2002 Aug 30;21(16):2409-19
pubmed: 12210625
Clin Microbiol Infect. 2014 Jun;20 Suppl 6:5-10
pubmed: 24506442
Antimicrob Resist Infect Control. 2019 Aug 13;8:137
pubmed: 31417673
Pediatr Infect Dis J. 2021 Mar 1;40(3):255-259
pubmed: 33538544
Clin Microbiol Infect. 2005 Feb;11(2):101-8
pubmed: 15679483
Pak J Med Sci. 2018 Jul-Aug;34(4):918-922
pubmed: 30190753
Am J Clin Pathol. 2016 Jun;145(6):858-61
pubmed: 27247378
Arch Dis Child Educ Pract Ed. 2021 Aug;106(4):244-250
pubmed: 33637581
Clin Microbiol Infect. 2018 Sep;24(9):964-969
pubmed: 29621616
J Antimicrob Chemother. 2018 Mar 1;73(suppl_4):iv13-iv19
pubmed: 29608752
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
J Antimicrob Chemother. 2018 Mar 1;73(suppl_4):iv6-iv12
pubmed: 29608751
Clin Infect Dis. 2018 May 17;66(11):1678-1686
pubmed: 29438475
Ann Intern Med. 1993 Aug 15;119(4):270-2
pubmed: 8328734
Clin Infect Dis. 2017 Jun 15;64(suppl_3):S368-S377
pubmed: 28575366
Clin Infect Dis. 2018 Aug 31;67(6):813-816
pubmed: 30169655
JAMA Pediatr. 2019 Apr 1;173(4):352-362
pubmed: 30742207
Pediatr Infect Dis J. 2020 Feb;39(2):114-120
pubmed: 31725552

Auteurs

Barbara Lucignano (B)

Unit of Microbiology and Diagnostic Immunology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Valeria Cento (V)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
IRCCS Humanitas Research Hospital, Milan, Italy.

Marilena Agosta (M)

Unit of Microbiology and Diagnostic Immunology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Federico Ambrogi (F)

Department of Clinical and Community Sciences, Università degli Studi di Milano, Milan, Italy.

Sami Albitar-Nehme (S)

Unit of Microbiology and Diagnostic Immunology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Livia Mancinelli (L)

Unit of Microbiology and Diagnostic Immunology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Giordana Mattana (G)

Unit of Microbiology and Diagnostic Immunology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Manuela Onori (M)

Unit of Microbiology and Diagnostic Immunology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Federica Galaverna (F)

Department of Pediatric Hematology and Oncology and of Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Luca Di Chiara (L)

Department of Cardiology and Cardiac Surgery, Pediatric Cardiac Intensive Care Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Tiziana Fragasso (T)

Department of Cardiology and Cardiac Surgery, Pediatric Cardiac Intensive Care Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Roberto Bianchi (R)

Anesthesia and Critical Care Medicine, ARCO Rome, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Francesca Tortora (F)

Anesthesia and Critical Care Medicine, ARCO Rome, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Cinzia Auriti (C)

Neonatal Intensive Care Unit, Medical and Surgical Department of the Fetus Newborn and Infant, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Andrea Dotta (A)

Neonatal Intensive Care Unit, Medical and Surgical Department of the Fetus Newborn and Infant, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Corrado Cecchetti (C)

Pediatric Intensive Care Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Salvatore Perdichizzi (S)

Pediatric Intensive Care Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Massimiliano Raponi (M)

Health Directorate, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Andrea Onetti Muda (A)

Department of Laboratories, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Silvia Nerini Molteni (S)

Chemical-Clinical and Microbiological Analysis, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Alberto Villani (A)

General Pediatrics Unit, Pediatric Emergency and General Pediatrics Department, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Franco Locatelli (F)

Department of Pediatric Hematology and Oncology and of Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Sapienza University of Rome, Rome, Italy.

Carlo Federico Perno (CF)

Unit of Microbiology and Diagnostic Immunology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Paola Bernaschi (P)

Unit of Microbiology and Diagnostic Immunology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH